migores1

PTPI Stock Earnings: Petros Pharmaceuticals Beats EPS, Beats Revenue for Q2 2024

VaselineAugust 17, 2024

0 1 minute read

PTPI Stock Earnings: Petros Pharmaceuticals Beats EPS, Beats Revenue for Q2 2024

PTPI Stock - PTPI Stock Earnings: Petros Pharmaceuticals Beats EPS, Beats Revenue for Q2 2024

Source: iQoncept / Shutterstock

Petros Pharmaceuticals (NASDAQ:PTPI) just reported results for the second quarter of 2024.

Petros Pharmaceuticals reported earnings per share of -37 cents. This was above analysts’ EPS estimate of -77 cents.
The company reported revenue of $1.42 million.
This was 1.50% better than analysts’ estimate for revenue of $1.40 million.

InvestorPlace Earnings is a project that uses data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways, including earnings per share and revenue, as well as how a company measures up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers about the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at [email protected].

Print article from InvestorPlace Media, https://investorplace.com/earning-results/2024/08/ptpi-stock-earnings-petros-pharmaceuticals-for-q2-of-2024/.

VaselineAugust 17, 2024

0 1 minute read

Vaseline

Related Articles

GDI Integrated Facility Services, Inc. (GDIFF) Transcript of Q2 2024 earnings call

EUR/GBP remains above 0.8450, potentially bolstered by German data

Alpha and Omega Semiconductor (NASDAQ:AOSL) Posts Earnings, Beats Estimates with $0.05 EPS

Shares of Tesla, Inc. (NASDAQ:TSLA) bought by M&R Capital Management Inc.